Introduction
The Capper Pass tin smelter operated on North Humberside in the UK from 1937 until 1991. Rio Tinto acquired the company in 1967 and owned it until decommissioning and site clearance was completed in 1995.
The smelter processed a variety of tin ore concentrates and residues to produce high purity tin as its main product and lead, copper, cadmium, antimony and silver as secondary products. Workers were potentially exposed to a variety of substances including tin, lead, antimony, arsenic, cadmium, sulphur dioxide, natural series radionuclides and combustion products.
Following Rio Tinto's acquisition, Capper Pass embarked on a major upgrade of the plant, including its environmental and hygiene systems, to replace plant and systems built in the 1930s. Greater management attention was also paid to occupational hygiene and environmental control, in line with rising regulatory standards and public expectations.
During the 1980s, concerns were raised about clusters of leukaemia and central nervous system tumours in the area surrounding the smelter, but no causal link was established [1 -5] . During the late 1990s, claims arose associating the smelter with deaths and ill-health among both employees and local residents, leading to the establishment in January 2002 of the Capper Pass Claims Review Scheme. These developments provided the impetus for the study reported here.
No epidemiological study of tin smelter workers has been reported and the toxicity of tin metal, together with its oxides and sulphides, is low [6] . However, several cohorts of copper smelter workers, in which major exposures would have included arsenic and sulphur dioxide [7 -14] and lead smelter workers, in which major exposures will have included lead, antimony and sulphur dioxide [15 -18] , have been studied. Data have also been reported for a single cohort of cadmium smelter workers, in which major exposures will have included cadmium, arsenic and sulphur dioxide [19 -24] , for a cohort of zinc -lead -cadmium smelter workers, in which major exposures will have included zinc, lead, arsenic, cadmium and sulphur dioxide [25] , and for a number of cohorts of workers exposed to cadmium in the production of cadmium alloys [26 -30] .
Excesses of lung cancer mortality are clearly apparent in the studies of copper smelters, the cadmium smelter and the zinc -lead -cadmium smelter. Arsenic has been identified as a major causative factor in the copper smelter cohorts [31] , and may have at least a contributory role in the cadmium smelter and zinc smelter cohorts [24, 25, 32] .
The objective of this study was to summarize the available mortality data for Capper Pass, to consider whether any aspect of the mortality experience of the cohort might be related to occupational exposures and, if so, to identify further analyses which would be capable of further investigating the potential role of occupational exposures.
Subjects and methods
The study was based on the company's employment and pension records, information obtained from electoral rolls, death certificates and information obtained from correspondence about the Claims Review Scheme with ex-employees. No use was made of company medical records.
Personnel records covering from 1937 to 1995 were available for all those employed during the period of Rio Tinto's ownership. We defined the cohort for analysis as those 1462 male workers employed for at least 12 months between 1/11/1967 and 28/7/1995. The completeness of this cohort was confirmed by matching against separate records created by the Pension Fund and a record of former employees created by Rio Tinto in 1992.
Deaths were initially identified by electronic search against the death registers for England and Wales for the period from 1982 to 2001 and by records held by the Pension Fund. Individuals were initially confirmed as alive through Pension Fund records and through information provided by claimants under the Claims Review Scheme. Searches on electoral rolls yielded a large number of further potential traces, a proportion of which could be positively confirmed using a mailing list established by Rio Tinto in connection with the Claims Review Scheme. Finally, the Office for National Statistics carried out a manual search of the pre-1982 death registers for England and Wales to identify any further deaths among the remaining untraced subjects. This search also incidentally confirmed that some of these subjects were alive.
As of 31/12/2001, we traced 380 subjects as dead and 998 subjects as alive, accounting for the vital status of 94.3% of the cohort. Most of the untraced subjects were first employed after 1970, and tended to have shorter than average periods of employment. Only 13 had projected ages of 60 or greater at the end of follow-up. Vital status and tracing data for the cohort are summarized in Tables 1 and 2 .
We obtained death certificates for 379 of the confirmed deaths either from the Pension Fund records or from Death Registry offices in the UK. The outstanding certificate was for an individual who died while resident in Norway.
Underlying causes of death were coded according to the contemporaneous revision of the International Classification of Diseases (ICD).
We calculated the expected numbers of deaths from age and calendar year cause-specific male mortality rates for England and Wales and for Humberside. For England and Wales, rates were available in electronic form up to 1998, and those for Humberside from 1979 through to 1997; for later years we used the last recorded rates and for Humberside the 1979 rates were assumed for all earlier years. The definition of disease groups used in the analysis is shown in the Appendix (see Supplementary data at Occupational Medicine Online).
For the main analysis, subjects entered follow-up and contributed to person-years at risk from the end of their 12-month minimum period of employment, or on 1 November 1967 if they had been employed for 12 months by that date. In subsidiary analyses, we applied lags of 5 and 10 years from the date of first employment to the entry of subjects into follow-up.
Subjects left follow-up and ceased to contribute to person-years at risk on the closing date of the study, on the date of death, or (for untraced subjects) at the date lost to follow-up.
The significance of the differences between the observed and expected numbers of deaths, and the confidence intervals on the calculated SMRs, were calculated on the assumption that the observed numbers of deaths follow a Poisson distribution. For disease groups with five or more deaths, we sought evidence for a positive trend in mortality with the length of employment using a Mantel -Haenszel test for trend [33] applied to nine categories of length of employment. We also calculated P-values for trend by simulation [34] for those disease groups with one-tailed P-values less than 0.1 on the Mantel -Haenszel test, based on less than 50 deaths. Table 3 shows that all causes mortality was slightly lower than that expected for the England and Wales population, but not significantly so (SMR 96, 95%CI 86 -106, P ¼ 0.42, 380 deaths). Malignant cancer mortality was slightly raised, but not significantly so (SMR 106, 95%CI 88 -127, P ¼ 0.53, 123 deaths). Lung cancer mortality was significantly elevated (SMR 161, 95%CI 124 -206, P , 0.001, 62 deaths). Mortality due to other individual cancers showed no significant excess or deficits, although the observed numbers of deaths were small and the resulting confidence intervals quite wide. There was an insignificant deficit in mortality from the main smoking related cancers other than lung cancer (SMR 76, 95%CI 41 -131, P ¼ 0.40, 13 deaths), these being cancers of the mouth and pharynx (other than salivary glands and nasopharynx), oesophagus, larynx, pancreas and bladder (ICD codes are defined in the Appendix). For lung cancer, the test for trend with length of employment approached significance at the 5% level (P ¼ 0.060). Table 4 shows no significant excess in non-cancer mortality. Hypertensive disease shows an excess which approaches significance (SMR 237, 95%CI 95 -489, P ¼ 0.063, 7 deaths), as does asthma (SMR 359, 95%CI 98 -918, P ¼ 0.056, 4 deaths), both results being based on small numbers of deaths. Mortality from nonmalignant diseases of the respiratory system is consistent with that expected (SMR 97, 95%CI 70 -131, P ¼ 0.90, 42 deaths). A significant deficit was seen for diabetes (SMR 0, 95%CI 0 -94, P ¼ 0.038, 0 deaths); numerically, the largest deficit in mortality was seen for ischaemic heart disease, which approaches significance (SMR 83, 95%CI 68.2 -101, P ¼ 0.066, 104 deaths). Mortality from non-cancer smoking related causes of death (ischaemic heart disease, cerebrovascular disease, arterial disease, pneumonia and bronchitis, chronic obstructive pulmonary disease and allied conditions) was consistent with expectation (SMR 93, 95%CI 80 -107, P ¼ 0.30, 192 deaths). Although mortality from diseases of the nervous system and sense organs was consistent with expectation (SMR 82, 95%CI 27 -191, P ¼ 0.86, 5 deaths), a significant trend with length of service was found (P ¼ 0.046). Tables 5 and 6 show SMRs relative to the Humberside population, which are very similar to those relative to national rates. The only material differences are that the deficit in ischaemic heart disease (SMR 77, 95%CI 63 -94, P ¼ 0.007, 104 deaths) and the small excess in hypertension (SMR 366, 95%CI 147 -753, P ¼ 0.008, 7 deaths) become significant. When the first 5 or 10 years of follow-up are discounted the results are not materially different to those discussed above. Table 7 shows SMRs for lung cancer for substrata of the cohort. Significantly elevated mortality rates for lung cancer are seen for: date of first employment 1955 or later, length of service between 15 and 25 years, time since first employment between 15 and 35 years and time since leaving employment less than 10 years.
Results

Discussion
Deviations of mortality from expectation within the cohort may result from chance, from general factors affecting industrial employment, or from specific factors relating to employment at the Capper Pass smelter. As many outcomes have been investigated in this study, a few results at or near the 5% significance level, such as the small number of excess deaths from hypertension, may arise purely by chance [35] . However, the excess of lung cancer stands out both by virtue of its significance level and the prior evidence from other nonferrous metal smelter studies, and is most unlikely to be due to chance.
The 'healthy worker' effect [36 -38] mainly impacts on those diseases that can be readily identified during selection for employment. After the Capper Pass smelter had closed down, the effect of the selection process and the residual survival advantage that it gave to the workers would be expected to decline. Assuming that there is no discrimination against smokers there should be little if any selection with respect to the risk of death from cancer more than a few years after first employment, and occupationally induced cancers must be expected to occur only after a prolonged latent period.
Manual labour tends to reduce the risk of ischaemic heart disease and may have contributed to the relatively low mortality from this cause.
The incidence of many diseases varies regionally and may need to be taken into account in comparing mortality rates in an industrial cohort with national rates [38] . However, in this study the results of analysis against Humberside mortality rates were very similar to those from analysis against national rates.
The prevalence of smoking has often been found to be above average in cohorts of industrial employees and has to be considered as a possible contributing cause to an elevated occupational mortality rate. Where figures for the influence of smoking on lung cancer mortality have been obtained for industrial cohorts similar to the Capper Pass cohort [39 -43] , they have seldom found smoking to account for an excess of more than about 20% above the national rate for lung cancer.
In the Capper Pass cohort, the mortality rates for smoking related diseases, other than lung cancer, are not raised. This weighs against the possibility that extra smoking could account for the excess mortality from lung cancer. Table 8 summarizes a number of studies of mortality in cohorts of non-ferrous smelter workers involving exposures comparable to those experienced at Capper Pass. Although the studies do not always report mortality ratios for the same disease groupings, comparisons can reasonably be made for mortality from all causes, all cancers, malignant and non-malignant respiratory disease and heart disease. For all causes of death, the Capper Pass cohort exhibits lower mortality than the cohorts at other smelters.
For all cancers, the results for the Capper Pass cohort appear intermediate between the copper smelters, three of which show significantly elevated mortality, and the lead smelters which are either consistent with, or significantly below, expectation.
For respiratory cancer (Figure 1) , a similar pattern is seen with the Capper Pass cohort intermediate between copper and lead smelters. All of the copper smelter studies show an excess of lung cancer, attributed to arsenic exposure [10, 11, 14] . The zinc -lead-cadmium smelter and the cadmium recovery smelter also show excess in lung cancer mortality. The excess in the zinc -lead -cadmium smelter was not associated with cumulative exposure to cadmium; positive associations were found with exposures to lead and arsenic, but it was not possible to determine whether the excess risk was due to these exposures [25] . Attribution of the excess at the cadmium recovery smelter to cadmium or arsenic exposures has been debated extensively [19, 21, 22, 24] .
For non-malignant respiratory disease (Figure 2) , the Capper Pass cohort shows mortality which is among the lowest for the other smelters studied.
For ischaemic heart disease ( Figure 3 ), all cohorts, with the exception of two of the copper smelters, show deficits in mortality. These deficits are significant or close to significant for the Capper Pass and the lead smelter cohorts. The cadmium recovery smelter study reports no data on ischaemic heart disease, but notes a highly significant deficit of all circulatory system diseases.
Overall, mortality in the Capper Pass cohort is comparable with, and in many specific instances lower than, that of the other cohorts from non-ferrous metal smelters. Nonetheless, the results from these cohorts provide support for the hypothesis that occupational exposures contribute to the observed excess of lung cancer in the Capper Pass cohort.
The observation that the test for a positive trend of lung cancer mortality with length of employment at Capper Pass approaches significance (P ¼ 0.060) is suggestive of an occupational hazard.
On the hypothesis that lung cancer mortality is related simply to cumulative occupational exposure to one or more carcinogens, and that length of service is a reasonable surrogate for cumulative exposure, one would expect higher mortality to be associated with long service and also (since levels of exposure are likely to have been higher in the past) with early dates of employment. The results in Table 7 do not conform to this simple pattern; there is not a progressive increase in mortality with length of service, and the earliest starters show the lowest mortality.
Nonetheless, the observation that the increased mortality is only seen at times greater than 15 years since first employment strengthens the evidence for the presence of an occupational hazard. The reduction in excess of lung cancer mortality with time since leaving employment is consistent with the action of an occupational carcinogen whose effect diminishes with time since exposure. Relationships of this type between the exposure and the mortality are well established for tobacco smoke [44] and ionizing radiation [45, 46] , and have also been suggested for arsenic [8] . Diminution of the effect of the causative factor(s) with time since exposure would reduce mortality of the earliest starters during the follow-up period and would also imply that the mortality will not increase linearly with cumulative exposure (or length of service).
Missing deaths from untraced study subjects could bias the study to some extent and could contribute to some of the features noted above. However, the personyears of follow-up potentially missed by the study correspond to an expectation of only 0.65 additional lung cancer deaths. Mortality of these subjects may be somewhat higher than for the cohort as a whole, but it seems unlikely that missing lung cancer deaths could substantially affect the observed pattern of mortality. As only two subjects employed prior to 1955 are untraced, missing deaths cannot account for the anomalously low mortality observed for this stratum. The results of this study are consistent with the hypothesis that a substantial proportion of the excess lung cancer mortality observed in the cohort may be attributed to exposure to one or more occupational carcinogens for which the effect on mortality diminishes with time since exposure. The deficit in ischaemic heart disease may be attributed to a protective effect from manual labour. The results provide no evidence for attribution of other excesses or deficits in mortality to factors associated with employment at Capper Pass.
